Cost-minimization analysis of degludec/liraglutide versus glargine/aspart: economic implications of the DUAL VII study outcomes

BACKGROUND: Diabetes represents a relevant public health problem worldwide due to its increasing prevalence and socioeconomic burden. There is no doubt that tight glycemic control reduces the development of diabetic complications such as the long-term costs related to the disease. The aim of our mod...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clinicoecon Outcomes Res
Asıl Yazarlar: Torre, Enrico, Bruno, Giacomo Matteo, Di Matteo, Sergio, Martinotti, Chiara, Oselin, Martina, Valentino, Maria Chiara, Parodi, Alessio, Bottaro, Luigi Carlo, Colombo, Giorgio Lorenzo
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove Medical Press 2018
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6067612/
https://ncbi.nlm.nih.gov/pubmed/30100746
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S169045
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller